With your help over the last 6 years, HRB CRCI has developed into a vital component of the Irish research ecosystem. However, its funding period ends on April 30th 2021 and the successor organisation, the National Clinical Trials Office, which is supported by a new HRB grant, will be hosted by UCC. It will continue to support the development of Irish clinical research. Inevitably, we may need to temporarily reduce our levels of activity during the transition period in May and June, however, we expect to be able to maintain all essential services. We apologise for any associated disruption and will do our best to minimize the resulting inconvenience.
From 1st May, please address any general enquiries for the new organisation or any other queries to email@example.com.
In addition, if you would like to be maintained on the mailing list, please forward a request to this effect to firstname.lastname@example.org.
I will continue to serve as PI in the new organisation and please feel free to contact me personally at email@example.com if I can assist in any way.
We would like to take this opportunity to thank you for your support of HRB CRCI and for your contribution to its success to date. We look forward to working with you in the coming years to further build on the important work that was delivered by HRB CRCI in supporting you in your Clinical Research endeavours.
Note – New emails addresses to be used from 1st May 2021:
For general clinical trial coordination supports and service queries contact: firstname.lastname@example.org
For clinical trial feasibility supports and services contact: email@example.com
Prof Joe Eustace, Principal Investigator, HRB CRCI
Director of HRB CRF Cork, UCC
HRB CRCI COO